Effects of systemic inflammation on relapse in early breast cancer
Abstract Chronic inflammation has been a proposed mechanism of resistance to aromatase inhibitors in breast cancer. Stratifying by HER2 status, a matched case-control study from the Wellness After Breast Cancer-II cohort was performed to assess whether or not elevated serum inflammatory biomarkers (...
Guardado en:
Autores principales: | Nicholas P. McAndrew, Lisa Bottalico, Clementina Mesaros, Ian A. Blair, Patricia Y. Tsao, Jennifer M. Rosado, Tapan Ganguly, Sarah J. Song, Phyllis A. Gimotty, Jun J. Mao, Angela DeMichele |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c1797f3e22424ecda689fbfd30194490 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse
por: A. B. Sanchez-Spitman, et al.
Publicado: (2021) -
Vitamin B6 deficiency disrupts serotonin signaling in pancreatic islets and induces gestational diabetes in mice
por: Ashley M. Fields, et al.
Publicado: (2021) -
Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases
por: Omar Alhalabi, et al.
Publicado: (2021) -
Association of Postoperative Radiotherapy Delay with Relapse and Metastasis in Women with Breast Cancer Using Penalized Cox Regression
por: Fatemeh Homaei Shandiz, et al.
Publicado: (2021) -
Ocular Involvement in Relapsing Polychondritis
por: Ken Fukuda, et al.
Publicado: (2021)